bromodeoxyuridine has been researched along with Dysembryoma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (88.89) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, A; Chaillet, JR | 1 |
| Ishida, H; Niwa, O; Sugahara, T; Yokota, Y | 1 |
| Martin, GR; Takagi, N | 1 |
| Asche, W; Colletta, G; King, RM; Nobis, P; Ostertag, W; Pennie, S; Warnecke, G | 1 |
| Hayashi, J; Tagashira, Y; Watanabe, T; Yoshida, MC | 1 |
| Avner, P; Fellous, M; Giovanella, BC; Nørgaard, JO; Rosén, A; Vaheri, A; Wartiovaara, J; Zeuthen, J | 1 |
| Martin, JC; Swartzendruber, DE; Travis, GL | 1 |
| McBurney, MW; Rogers, BJ | 1 |
| Dixon, FJ; Gautsch, JW; Speers, WC | 1 |
| Andrews, PW; Fenderson, BA; Hakomori, S; Nudelman, E | 1 |
| Kosaka, M; Matsumoto, K; Nishimune, Y; Nishina, Y; Sakuda, M; Sumi, T; Takeda, M | 1 |
| Domon, OE; Hinson, WG; Kodell, RL; McGarrity, LJ; Morris, SM | 1 |
| Andrews, PW; Dignazio, M; Gönczöl, E; Oosterhuis, JW; Plotkin, SA | 1 |
| Hatano, M; Kamiya, S; Nakamura, S; Ogura, H; Ogura, T; Sato, H; Tanaka, J | 1 |
| Mitra, NS; Moore, EE; Moritz, EA | 1 |
| Izutsu, T; Kagabu, T; Kaneko, S; Matsuda, M; Nishiya, I; Yoshizaki, A | 1 |
| Hoshino, T | 1 |
| De Armond, S; Edwards, MS; Hoshino, T; Murovic, JA; Nagashima, T | 1 |
1 review(s) available for bromodeoxyuridine and Dysembryoma
| Article | Year |
|---|---|
Proliferative potential of pediatric brain tumors.
Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Bromodeoxyuridine; Cell Division; Child; Child, Preschool; Female; Glioma; Humans; Male; Meningioma; Teratoma | 1987 |
17 other study(ies) available for bromodeoxyuridine and Dysembryoma
| Article | Year |
|---|---|
Role of the inositol polyphosphate-4-phosphatase type II Inpp4b in the generation of ovarian teratomas.
Topics: Animals; Bromodeoxyuridine; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Genotype; Granulosa Cells; Immunoblotting; Immunohistochemistry; In Situ Hybridization; Mice; Ovarian Follicle; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction; Statistics, Nonparametric; Teratoma; Transgenes | 2013 |
Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells.
Topics: Animals; Azacitidine; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Line; DNA, Viral; Gene Expression Regulation; Genes, Viral; Methylation; Mice; Moloney murine leukemia virus; Recombination, Genetic; Teratoma; Transcription, Genetic; Transfection; Tretinoin | 1983 |
Studies of the temporal relationship between the cytogenetic and biochemical manifestations of X-chromosome inactivation during the differentiation of LT-1 teratocarcinoma stem cells.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Chromosome Banding; DNA Replication; Dosage Compensation, Genetic; Endoderm; Female; Glucosephosphate Dehydrogenase; Metaphase; Mice; Microscopy, Fluorescence; Phosphogluconate Dehydrogenase; Stem Cells; Teratoma; Time Factors; X Chromosome | 1984 |
Lack of retrovirus gene expression in somatic cell hybrids of friend cells and teratocarcinoma cells with a teratocarcinoma phenotype.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Transformation, Viral; Clone Cells; Friend murine leukemia virus; Genes, Viral; Hybrid Cells; Leukemia, Experimental; Mice; Phenotype; RNA, Viral; Teratoma | 1984 |
Effect of mitochondrial DNA transmitted cytoplasmically from nontumorigenic to tumorigenic rat cells on the phenotypic expression of tumorigenicity.
Topics: Animals; Bromodeoxyuridine; Cell Line; Chloramphenicol; DNA, Mitochondrial; Drug Resistance; Glioma; Karyotyping; Male; Mice; Mice, Nude; Phenotype; Rats; Teratoma; Transfection | 1984 |
Characterization of a human ovarian teratocarcinoma-derived cell line.
Topics: Antigens, Surface; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; Cells, Cultured; Embryonic Induction; Female; Genetic Markers; Hot Temperature; Humans; Karyotyping; Ovarian Neoplasms; Phenotype; Teratoma | 1980 |
Flow cytometric analysis of the effect 5-bromodeoxyuridine on mouse teratocarcinoma cells.
Topics: Alkaline Phosphatase; Animals; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Line; Cytological Techniques; DNA, Neoplasm; Electric Conductivity; Esterases; Mice; Teratoma | 1980 |
Isolation of male embryonal carcinoma cells and their chromosome replication patterns.
Topics: Animals; Bromodeoxyuridine; Cell Line; DNA Replication; Interphase; Karyotyping; Male; Mice; Mice, Inbred C3H; Sex Chromosomes; Teratoma; Y Chromosome | 1982 |
Silent infection of murine embryonal carcinoma cells by Moloney murine leukemia virus.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Transformation, Viral; Clone Cells; Gene Expression Regulation; Mice; Moloney murine leukemia virus; Neoplasms, Experimental; Teratoma; Virus Activation; Virus Replication | 1980 |
Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
Topics: Acetamides; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Bromodeoxyuridine; Cell Membrane; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Glycolipids; Humans; Membrane Lipids; Retinoids; Teratoma; Tumor Cells, Cultured | 1990 |
Inhibition of DNA synthesis causes stem cell differentiation: induction of teratocarcinoma F9 cell differentiation with nucleoside analogues of DNA-synthesis inhibitors and their inducing abilities counterbalanced specifically by normal nucleosides.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cytarabine; DNA Replication; DNA, Neoplasm; Floxuridine; Hematopoietic Stem Cells; Idoxuridine; Kinetics; Mice; Mutation; Nucleosides; Plasminogen Activators; Teratoma; Thymidine Kinase | 1989 |
Flow cytometric analysis of bromodeoxyuridine-induced inhibition of cell proliferation in the human teratocarcinoma-derived cell line, P3.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Sister Chromatid Exchange; Teratoma; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
Topics: Acetamides; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Cisplatin; Clone Cells; Cyclic AMP; Cytarabine; Dimethyl Sulfoxide; Humans; Idoxuridine; Kinetics; Neurons; Teratoma; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |
Latent infection of human ovarian teratocarcinoma cells with human cytomegalovirus. Brief report.
Topics: Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Cytomegalovirus; Female; Humans; Ovarian Neoplasms; Teratoma; Tretinoin; Virus Replication | 1986 |
Differentiation of F9 embryonal carcinoma cells. Differences in the effects of retinoic acid, 5-bromodeoxyuridine, and N'-N'-dimethylacetamide.
Topics: Acetamides; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Transformation, Neoplastic; Cyclic AMP; Fluorescent Antibody Technique; Laminin; Phenotype; Teratoma; Tretinoin | 1986 |
Appreciation for malignancy on ovarian neoplasm by monoclonal antibody of BrdUrd.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Bromodeoxyuridine; Cystadenocarcinoma; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Teratoma | 1988 |
Cell kinetics analysis in a case of teratoma of the thoracic spine.
Topics: Bromodeoxyuridine; Humans; Infant, Newborn; Male; Spinal Cord Neoplasms; Teratoma | 1986 |